Qijin Zhai
Xuzhou Medical College(CN)Second People’s Hospital of Huai’an(CN)
Publications by Year
Research Areas
Acute Ischemic Stroke Management, Stroke Rehabilitation and Recovery, Intracerebral and Subarachnoid Hemorrhage Research, Alzheimer's disease research and treatments, Cerebrovascular and Carotid Artery Diseases
Most-Cited Works
- → Mesenchymal stem cells protect neurons against hypoxic-ischemic injury via inhibiting parthanatos, necroptosis, and apoptosis, but not autophagy(2016)53 cited
- → Prognostic Value of Plasma Trimethylamine N-Oxide Levels in Patients with Acute Ischemic Stroke(2019)49 cited
- → Efficacy and Safety of Recombinant Human Prourokinase in the Treatment of Acute Ischemic Stroke Within 4.5 Hours of Stroke Onset(2023)44 cited
- → Tenecteplase Thrombolysis for Stroke up to 24 Hours After Onset With Perfusion Imaging Selection: The CHABLIS-T II Randomized Clinical Trial(2025)33 cited
- → Efficacy and Safety of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke(2023)30 cited
- → 2-(2-benzofuranyl)-2-imidazoline (2-BFI) improved the impairments in AD rat models by inhibiting oxidative stress, inflammation and apoptosis(2017)22 cited
- → Role of plasminogen activator inhibitor‑1 in the diagnosis and prognosis of patients with Parkinson's disease(2018)20 cited
- → High plasma levels of trimethylamine N-oxide are associated with poor outcome in intracerebral hemorrhage patients(2020)20 cited
- → miR-190a-3p Promotes Proliferation and Migration in Glioma Cells via YOD1(2021)19 cited
- → Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the umbrella phase IIa CHABLIS-T randomised clinical trial(2024)18 cited